Skip to main content
. 2017;18(10):2839–2844. doi: 10.22034/APJCP.2017.18.10.2839

Table 2.

Results of CYP2C19 Genotype and Eradication Rate (Shown in Parentsese) According to Treatment Regimens

CYP2C19 genotype (n=103) 7-day plus probiotic (n=26) 7-day plus placebo (n=25) 14-day plus probiotic (n=26) 14-day plus placebo (n=26)
PM no. (n=11; 10.7%) 3 (100%) 1 (0.00%) 5 (100%) 2 (100%)
IM no. (n=48; 46.6%) 12 (100%) 13 (92.3%) 9 (88.9%) 14 (92.9%)
RM no. (n=44; 42.7%) 11 (100%) 11 (90.9%) 12 (91.7%) 10 (100%)

*number in parenteses are eradication rates